Patent ID: 8772042
Filing Date: 2014-07-08
Classification: C07K,G01N

Abstract:
1. A method for assessing the state of Alzheimer's disease in a subject, wherein the method comprises detecting in a sample from the subject at least five distinct polypeptides meeting the following criteria: a first polypeptide having the amino acid sequence of SEQ ID NO: 17; a second polypeptide having the amino acid sequence of SEQ ID NO: 1 or 2; a third polypeptide having the amino acid sequence of SEQ ID NO: 3; a fourth polypeptide having the amino acid sequence of SEQ ID NO: 4, 5, or 6; and a fifth polypeptide having the amino acid sequence selected from the group consisting of SEQ ID NO: 7 to SEQ ID NO: 16.